2 Minute Medicine Rewind July 6 – July 12, 2015
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer Cancer immunotherapy seeks to up regulate immune activators and down regulate ...
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer Cancer immunotherapy seeks to up regulate immune activators and down regulate ...
1. Radiofrequency ablation with a multiple-electrode switching system can safely be used to successfully treat lung tumors 2-5 cm in ...
1. An electronic health record-based trigger algorithm was developed to identify patients with chest imaging results suspicious for malignancy at ...
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Effect ...
1. In patients with T790M EGFR-mutated treatment-resistant lung cancer who were treated with rociletinib, there was an objective response rate ...
1. When applied to the original NLST cohort, Lung-RADS lung cancer screening criteria had a lower false positive rate, a ...
1. Among patients with non-small-cell lung cancer (NSCLC) and ALK gene rearrangements, treatment with oral crizotinib therapy was superior to ...
Originally published by Harvard Health. What Is It? One of the most common cancers, lung cancer usually occurs when a cancer-causing ...
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Cost-Effectiveness ...
1. Screening for lung cancer with low-dose CT was found to cost ~$81,000 per quality-adjusted life-year (QALY) gained. Evidence Rating ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.